14.89 USD
-0.18
1.19%
Updated Aug 26, 1:38 PM EDT
1 day
-1.19%
5 days
0.07%
1 month
7.66%
3 months
-18.90%
6 months
-11.37%
Year to date
-4.73%
1 year
-16.82%
5 years
-36.91%
10 years
-38.19%
 

About: Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Employees: 9,717

0
Funds holding %
of 7,431 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 10

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

12% more funds holding

Funds holding: 60 [Q1] → 67 (+7) [Q2]

7% more capital invested

Capital invested by funds: $188M [Q1] → $202M (+$13.1M) [Q2]

0.9% more ownership

Funds ownership: 22.66% [Q1] → 23.56% (+0.9%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$14
6%
downside
Avg. target
$16.75
12%
upside
High target
$19.50
31%
upside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
Citigroup
Leandro Bastos
6%downside
$14
Neutral
Upgraded
29 Jul 2025
UBS
Andre Salles
31%upside
$19.50
Neutral
Maintained
12 Jun 2025

Financial journalist opinion

Based on 9 articles about AFYA published over the past 30 days

Positive
Seeking Alpha
1 week ago
Afya's Multiple Is Back To Reasonable Levels, But Market Saturation Is Real
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.
Afya's Multiple Is Back To Reasonable Levels, But Market Saturation Is Real
Neutral
Seeking Alpha
1 week ago
Afya Limited (AFYA) Q2 2025 Earnings Call Transcript
Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev dos Santos - JPMorgan Chase & Co, Research Division Mauricio I Cepeda - Morgan Stanley, Research Division Renan Prata - Citigroup Inc. Exchange Research Samuel Campos Alves - Banco BTG Pactual S.A.
Afya Limited (AFYA) Q2 2025 Earnings Call Transcript
Neutral
Business Wire
1 week ago
Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highligh.
Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results
Neutral
Business Wire
1 week ago
Afya Limited Announces a New Share Repurchase Program
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning.
Afya Limited Announces a New Share Repurchase Program
Positive
Zacks Investment Research
2 weeks ago
Best Growth Stocks to Buy for August 6th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 6th:
Best Growth Stocks to Buy for August 6th
Positive
Zacks Investment Research
3 weeks ago
Best Growth Stocks to Buy for August 4th
PRIM, AFYA and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2025.
Best Growth Stocks to Buy for August 4th
Positive
Zacks Investment Research
3 weeks ago
Best Growth Stocks to Buy for July 31st
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2025.
Best Growth Stocks to Buy for July 31st
Positive
Zacks Investment Research
4 weeks ago
Best Growth Stocks to Buy for July 29th
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 29, 2025.
Best Growth Stocks to Buy for July 29th
Positive
Zacks Investment Research
4 weeks ago
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors?
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
1 month ago
Is Afya (AFYA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Afya (AFYA) Stock Undervalued Right Now?
Charts implemented using Lightweight Charts™